Get the Stockscreener App
57.57
1.61%
0.91
After Hours:
57.57
Prestige Consumer Healthcare Inc stock is traded at $57.57, with a volume of 323.18K.
It is up +1.61% in the last 24 hours and down -6.31% over the past month.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
See More
Previous Close:
$56.66
Open:
$56.73
24h Volume:
323.18K
Relative Volume:
0.69
Market Cap:
$2.72B
Revenue:
$1.10B
Net Income/Loss:
$186.50M
P/E Ratio:
15.22
EPS:
3.7817
Net Cash Flow:
$267.19M
1W Performance:
+3.62%
1M Performance:
-6.31%
6M Performance:
-5.51%
1Y Performance:
-28.87%
1-Day Range:
$56.07
$57.65
1-Week Range:
$54.93
$57.65
52-Week Range:
$51.24
$89.37
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Name
Prestige Consumer Healthcare Inc
Sector
Phone
(914) 524-6800
Address
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
57.57 | 2.68B | 1.10B | 186.50M | 267.19M | 3.7817 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 56.39B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
120.76 | 50.93B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.66 | 43.19B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.61 | 36.99B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
577.58 | 25.36B | 3.18B | 1.33B | 1.04B | 27.90 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Upgrade | Sidoti | Neutral → Buy |
| Dec-09-24 | Downgrade | Sidoti | Buy → Neutral |
| Jun-21-24 | Upgrade | DA Davidson | Neutral → Buy |
| Nov-17-22 | Initiated | Canaccord Genuity | Buy |
| May-10-22 | Upgrade | Jefferies | Hold → Buy |
| May-09-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-07-20 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-29-20 | Upgrade | Sidoti | Neutral → Buy |
| Apr-14-20 | Downgrade | Jefferies | Buy → Hold |
| Apr-07-20 | Resumed | Sidoti | Neutral |
| Mar-26-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-24-20 | Initiated | Oppenheimer | Perform |
| Mar-19-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-04-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jun-02-17 | Upgrade | Jefferies | Underperform → Hold |
| May-22-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-27-16 | Reiterated | B. Riley & Co. | Buy |
| Nov-17-16 | Initiated | Gabelli & Co | Buy |
| Aug-12-16 | Upgrade | Sidoti | Neutral → Buy |
| Mar-08-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Feb-05-16 | Initiated | Piper Jaffray | Overweight |
| Nov-30-15 | Downgrade | Jefferies | Hold → Underperform |
| Apr-28-14 | Reiterated | B. Riley & Co. | Buy |
| Apr-28-14 | Reiterated | Oppenheimer | Outperform |
| Jul-09-13 | Initiated | B. Riley & Co. | Buy |
View All
Prestige Consumer Healthcare Inc Stock (PBH) Latest News
Prestige Consumer Health to acquire Breathe Right for $1.045B - MSN
Aug Highlights: Will Prestige Consumer Healthcare Inc benefit from AI trendsIPO Watch & Community Verified Swing Trade Signals - baoquankhu1.vn
Understanding the Setup: (PBH) and Scalable Risk - Stock Traders Daily
Why Prestige Consumer Healthcare (PBH) Is Down 5.8% After Heightened Regulatory Scrutiny On Its OTC Portfolio - Sahm
Prestige Consumer Healthcare Takes Deep International Breath With Breathe Right Deal - Citeline News & Insights
Prestige Consumer Healthcare Inc. (PBH) stock price, news, quote and history - Yahoo Finance Singapore
Has Prestige Consumer Healthcare (PBH) Fallen Too Far After Its 32% One-Year Share Price Drop - Yahoo Finance
Panic Selling: Can Prestige Consumer Healthcare Inc continue delivering strong returns2026 Catalysts & Long-Term Growth Plans - baoquankhu1.vn
Prestige Consumer Healthcare narrows fiscal 2026 revenue outlook to $1.1B while advancing Clear Eyes supply recovery - MSN
Prestige Consumer Healthcare (PBH) Is Down 10.3% After Rising FTC Scrutiny and Bearish SignalsWhat's Changed - Yahoo Finance
PBH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Prestige Consumer Healthcare Inc (PBH) Trading Down 6.76% on Apr 2 - GuruFocus
Prestige Consumer Healthcare stock hits 52-week low at 56.86 USD - Investing.com Australia
Prestige Consumer Healthcare In (PBH) Stock Forecasts - Yahoo Finance
PBH Plummets 8.6% Intraday: Is This A Deep Correction Or A Buying Opportunity? - Bitget
Prestige Consumer Healthcare (NYSE:PBH) Hits New 12-Month LowHere's Why - MarketBeat
Prestige Consumer Healthcare stock hits 52-week low at 56.86 USD By Investing.com - Investing.com South Africa
Allspring Global Investments Holdings LLC Acquires 21,085 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Inc. (PBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
The Technical Signals Behind (PBH) That Institutions Follow - Stock Traders Daily
Prestige bets $1 billion on world's most iconic nasal strip - MSN
PBH Technical Analysis & Stock Price Forecast - intellectia.ai
Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives Consensus Recommendation of "Hold" from Brokerages - marketbeat.com
Vanguard (PBH) amendment shows 0 shares; reporting split after Jan 12, 2026 - Stock Titan
Swing Trade: Can Prestige Consumer Healthcare Inc sustain earnings growthShare Buyback & Growth Oriented Trading Recommendations - baoquankhu1.vn
Market Catalysts: Can Prestige Consumer Healthcare Inc continue delivering strong returns2026 Major Catalysts & Daily Oversold Bounce Ideas - baoquankhu1.vn
Prestige Consumer Healthcare’s (PBH) Free Cash Flow to Enterprise Value Stood at 6.5% - Insider Monkey
Congress Asset Management Co. Has $20.91 Million Stock Position in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Nordea Investment Management AB Has $37.81 Million Holdings in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Inc. $PBH Shares Bought by JPMorgan Chase & Co. - marketbeat.com
User - The Chronicle-Journal
Foundation Consumer Healthcare sells portion of consumer health business - Drug Store News
Aug Big Picture: What are analysts price targets for Prestige Consumer Healthcare Inc2026 Price Swings & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Prestige Consumer to buy Breathe Right brand in $1.05 billion deal - msn.com
Prestige Consumer Healthcare Inc. (PBH) Breathe RightM&A CallSlideshow (NYSE:PBH) 2026-03-21 - Seeking Alpha
Published on: 2026-03-21 21:46:33 - baoquankhu1.vn
Prestige Consumer Healthcare to acquire Breathe Right for $1.05bn By Investing.com - Investing.com Australia
Health Care Down Amid Regulatory Fears -- Health Care Roundup - MarketScreener
PBH: $1.045B acquisition of Breathe Right boosts revenue, margins, and global scale with low integration risk - TradingView
Prestige Consumer Healthcare: Adding A Prestigious Brand (NYSE:PBH) - Seeking Alpha
Precision Trading with Prestige Consumer Healthcare Inc. (PBH) Risk Zones - Stock Traders Daily
Prestige Consumer Healthcare to Buy Breathe Right, Other Brands for $1.045 Billion - WSJ
Prestige Consumer Healthcare Acquires Breathe Right for $1.045 Billion, Expanding Global OTC Portfolio and Enhancing Financial Profile 13 - Minichart
Prestige Picks Up Breathe Right In $1.05B Deal - Law360
Prestige Consumer Healthcare (NYSE:PBH) Shares Gap UpTime to Buy? - MarketBeat
Prestige Consumer Healthcare to Acquire Consumer Health, Wellness Brands Portfolio in $1.05 Billion Deal - marketscreener.com
Prestige Consumer Healthcare To Acquire Breathe Right - citybiz
Prestige Consumer Healthcare to acquire Breathe Right for $1.05bn - Investing.com
Prestige Consumer Healthcare Inc Stock (PBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):